Kevin DeMass, RPh, is the owner and leader of a talented team of professionals that encounters a wide variety of patients, ailments, and medications.
Vaccination is first line of defense.
A new systematic review demonstrates efficacy of direct-acting antiviral therapies and supports a recommendation for universal screening of hepatitis C virus.
The FDA announced the first drug shortage due to COVID-19, and pharmacies are having challenges keeping face masks and hand sanitizers stocked.
Pyrimethamine (Daraprim) tablets are used to treat toxoplasmosis.
British study supports exogenous boosting theory.
Rimegepant (Nurtec ODT, Biohaven),a fast-acting orally disintegrating tablet, delivers quick and sustained efficacy for patients with migraine.
In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.
A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.
The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.